Current status of patients with hip fracture in Japan: A nationwide survey.

IF 1.4 4区 医学 Q3 ORTHOPEDICS
Kazuhide Inage, Naoki Kondo, Satoshi Komatsubara, Yukio Nakamura, Nobukazu Okimoto, Junichi Takada, Naohisa Miyakoshi, Takeshi Miyamoto, Satoshi Mori, Hiroshi Ozawa, Satoshi Ikeda
{"title":"Current status of patients with hip fracture in Japan: A nationwide survey.","authors":"Kazuhide Inage, Naoki Kondo, Satoshi Komatsubara, Yukio Nakamura, Nobukazu Okimoto, Junichi Takada, Naohisa Miyakoshi, Takeshi Miyamoto, Satoshi Mori, Hiroshi Ozawa, Satoshi Ikeda","doi":"10.1016/j.jos.2025.05.014","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although surgical treatment is the standard of care for most hip fractures, the post-fracture management of osteoporosis remains challenging. This study aimed to elucidate the status of osteoporosis treatment, subsequent fracture rates, mortality rates, and changes in residential status and care levels among hip fracture patients in Japan, and to explore strategies for fracture prevention and extension of healthy life expectancy.</p><p><strong>Methods: </strong>This study included patients with hip fractures treated at approximately 3000 orthopaedic facilities nationwide during July 2020. Data was collected via web-based surveys at the time of injury and 6 and 12 months post-injury.</p><p><strong>Results: </strong>A total of 6705 patients were registered from 1309 facilities (mean age: 82.9 ± 0.7 years; 86.4 % were female). The surgery rate was 94.8 %, with 62.1 % undergoing osteosynthesis and 37.9 % receiving hemiarthroplasty or total hip arthroplasty. Osteoporosis treatment rates gradually increased from 23.0 % at the time of injury to 44.8 % at 6 months and 47.3 % at 12 months, although the rates remained suboptimal. Active vitamin D3-based medications were the most commonly used medications, accounting for approximately 60 % of cases. The cumulative 12-month mortality rate was 10.0 %, and the incidence of new fractures was 11.0 %. The main fracture sites were the contralateral proximal femur, vertebral, and proximal humerus. The most common reason for non-treatment was \"patient's decision.\" Among patients who were not enrolled in long-term care insurance at the time of injury, 66.1 % had newly obtained care level certification by 12 months after injury. The proportion of patients who returned home among those living at home at the time of injury was 80.7 % at 6 months and 96.8 % at 12 months, respectively.</p><p><strong>Conclusions: </strong>Osteoporosis treatment rates after hip fractures remain low, indicating the need for more proactive intervention, including secondary fracture prevention. This study also highlights the importance of early rehabilitation and continuous support.</p>","PeriodicalId":16939,"journal":{"name":"Journal of Orthopaedic Science","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Orthopaedic Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jos.2025.05.014","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Although surgical treatment is the standard of care for most hip fractures, the post-fracture management of osteoporosis remains challenging. This study aimed to elucidate the status of osteoporosis treatment, subsequent fracture rates, mortality rates, and changes in residential status and care levels among hip fracture patients in Japan, and to explore strategies for fracture prevention and extension of healthy life expectancy.

Methods: This study included patients with hip fractures treated at approximately 3000 orthopaedic facilities nationwide during July 2020. Data was collected via web-based surveys at the time of injury and 6 and 12 months post-injury.

Results: A total of 6705 patients were registered from 1309 facilities (mean age: 82.9 ± 0.7 years; 86.4 % were female). The surgery rate was 94.8 %, with 62.1 % undergoing osteosynthesis and 37.9 % receiving hemiarthroplasty or total hip arthroplasty. Osteoporosis treatment rates gradually increased from 23.0 % at the time of injury to 44.8 % at 6 months and 47.3 % at 12 months, although the rates remained suboptimal. Active vitamin D3-based medications were the most commonly used medications, accounting for approximately 60 % of cases. The cumulative 12-month mortality rate was 10.0 %, and the incidence of new fractures was 11.0 %. The main fracture sites were the contralateral proximal femur, vertebral, and proximal humerus. The most common reason for non-treatment was "patient's decision." Among patients who were not enrolled in long-term care insurance at the time of injury, 66.1 % had newly obtained care level certification by 12 months after injury. The proportion of patients who returned home among those living at home at the time of injury was 80.7 % at 6 months and 96.8 % at 12 months, respectively.

Conclusions: Osteoporosis treatment rates after hip fractures remain low, indicating the need for more proactive intervention, including secondary fracture prevention. This study also highlights the importance of early rehabilitation and continuous support.

日本髋部骨折患者的现状:一项全国性调查。
背景:尽管手术治疗是大多数髋部骨折的标准治疗方法,但骨折后骨质疏松症的治疗仍然具有挑战性。本研究旨在了解日本髋部骨折患者的骨质疏松治疗状况、后续骨折发生率、死亡率、居住状况和护理水平的变化,并探讨骨折预防和延长健康预期寿命的策略。方法:本研究纳入了2020年7月在全国约3000家骨科机构接受治疗的髋部骨折患者。在受伤时以及受伤后6个月和12个月通过网络调查收集数据。结果:1309家机构共登记6705例患者(平均年龄:82.9±0.7岁;86.4%为女性)。手术率为94.8%,其中62.1%行骨融合术,37.9%行半髋关节置换术或全髋关节置换术。骨质疏松症的治愈率从损伤时的23.0%逐渐上升到6个月时的44.8%和12个月时的47.3%,尽管治愈率仍然不理想。基于活性维生素d3的药物是最常用的药物,约占病例的60%。累计12个月死亡率为10.0%,新发骨折发生率为11.0%。主要骨折部位为对侧股骨近端、椎体和肱骨近端。不接受治疗最常见的原因是“病人的决定”。在受伤时未参加长期护理保险的患者中,66.1%的患者在受伤后12个月内获得了新获得的护理水平认证。伤后6个月和12个月时,患者返回家中的比例分别为80.7%和96.8%。结论:髋部骨折后骨质疏松的治愈率仍然很低,表明需要更积极的干预,包括二级骨折预防。本研究还强调了早期康复和持续支持的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Orthopaedic Science
Journal of Orthopaedic Science 医学-整形外科
CiteScore
3.00
自引率
0.00%
发文量
290
审稿时长
90 days
期刊介绍: The Journal of Orthopaedic Science is the official peer-reviewed journal of the Japanese Orthopaedic Association. The journal publishes the latest researches and topical debates in all fields of clinical and experimental orthopaedics, including musculoskeletal medicine, sports medicine, locomotive syndrome, trauma, paediatrics, oncology and biomaterials, as well as basic researches.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信